AIRLINK 66.80 Increased By ▲ 2.21 (3.42%)
BOP 5.67 Increased By ▲ 0.07 (1.25%)
CNERGY 4.63 Decreased By ▼ -0.09 (-1.91%)
DFML 22.32 Increased By ▲ 1.56 (7.51%)
DGKC 69.76 Decreased By ▼ -1.64 (-2.3%)
FCCL 19.62 Decreased By ▼ -0.33 (-1.65%)
FFBL 30.20 Decreased By ▼ -0.25 (-0.82%)
FFL 9.90 Decreased By ▼ -0.15 (-1.49%)
GGL 10.05 No Change ▼ 0.00 (0%)
HBL 115.70 Increased By ▲ 4.70 (4.23%)
HUBC 130.51 Decreased By ▼ -0.33 (-0.25%)
HUMNL 6.74 Decreased By ▼ -0.11 (-1.61%)
KEL 4.35 Decreased By ▼ -0.04 (-0.91%)
KOSM 4.80 Increased By ▲ 0.46 (10.6%)
MLCF 37.19 Decreased By ▼ -0.56 (-1.48%)
OGDC 133.55 Decreased By ▼ -0.30 (-0.22%)
PAEL 22.60 Increased By ▲ 0.03 (0.13%)
PIAA 26.70 Decreased By ▼ -0.85 (-3.09%)
PIBTL 6.25 Decreased By ▼ -0.06 (-0.95%)
PPL 113.95 Decreased By ▼ -1.00 (-0.87%)
PRL 27.15 Decreased By ▼ -0.07 (-0.26%)
PTC 16.13 Decreased By ▼ -0.37 (-2.24%)
SEARL 59.70 Decreased By ▼ -1.00 (-1.65%)
SNGP 66.50 Increased By ▲ 1.35 (2.07%)
SSGC 11.21 Decreased By ▼ -0.14 (-1.23%)
TELE 8.94 Decreased By ▼ -0.03 (-0.33%)
TPLP 11.34 Increased By ▲ 0.09 (0.8%)
TRG 69.36 Increased By ▲ 0.31 (0.45%)
UNITY 23.45 Increased By ▲ 0.01 (0.04%)
WTL 1.36 Decreased By ▼ -0.03 (-2.16%)
BR100 7,312 Decreased By -12.8 (-0.17%)
BR30 24,106 Increased By 48.2 (0.2%)
KSE100 70,484 Decreased By -60.9 (-0.09%)
KSE30 23,203 Increased By 11.5 (0.05%)
World

S.Africa virus strain 'offers immunity against other variants'

  • Identified late last year, the variant fuelled South Africa's second wave of infection and delayed the start of vaccinations in February.
Published March 3, 2021

JOHANNESBURG: A new study has shown that people previously infected by the Covid-19 variant identified in South Africa have better immunity against other coronavirus mutations, experts said Wednesday.

The findings, from preliminary research by the team of South African scientists who identified the variant dubbed 501Y.V2, raise hopes that vaccines modelled on the strain could protect against future mutations.

Identified late last year, the variant fuelled South Africa's second wave of infection and delayed the start of vaccinations in February.

Scientists said Wednesday that plasma collected from people infected with the variant had "good neutralising activity", including against "first wave" viruses and potentially other variants of concern.

After the antibodies were tested against the original strain and another identified in Brazil, "results are showing a clear sense of direction", virologist Tulio de Oliveira said in a video conference.

Health Minister Zweli Mkhize told the same meeting that the discovery was "good news for all" as it presented a huge boost to the control of the pandemic.

Coronavirus mutations -- some more contagious -- had put a damper on global vaccination programmes after existing shots were found to offer less protection against them.

Manufacturers have in recent weeks raced to tweak their formulas in response to the spread of newer variants.

Comments

Comments are closed.